IVUS correlated to a 27% reduction in major adverse arterial limb events and a 28% reduction in repeat venous interventions, hospitalization or death during the largest ever real-word clinical analysis.
Test
Dr Pliagas discusses his retrospective study, recently published in JCLI, in which he and his co-investigators sought to demonstrate safety and performance of the Terumo Glidesheath Slender for tibiopedal access. Initially, tibiopedal access was considered a very experimental technique, but over the past few years, Dr Pliagas and his colleagues have learned to routinely gain access to vessels from below, using this technique.
Drs Driver and Neville discuss the crucial component of podiatry in the multidisciplinary treatment of CLTI.
Dr John H Rundback discusses his recent JCLI article, "Patterns of Failure in Deep Venous Arterialization and Implications for Management."
Daniel Clair, MD, Chair of Vascular Surgery from Vanderbilt University Medical Center discusses a number of interesting findings discovered during the BEST CLI trial.
Study co-author George Adams, MD, offers further insight into the topic in the video commentary below.